Mathias Zink Selected Research

Mathias Zink Research Topics

Disease

38	Schizophrenia (Dementia Praecox) 01/2022 - 02/2004
19	Psychotic Disorders (Schizoaffective Disorder) 03/2022 - 01/2004
4	Body Weight (Weight, Body) 02/2017 - 09/2010
3	Neurobehavioral Manifestations 05/2015 - 03/2010
3	Treatment-Resistant Schizophrenia 11/2005 - 01/2004
2	Depressive Disorder (Melancholia) 08/2010 - 06/2005
2	Fetal Alcohol Spectrum Disorders 03/2005 - 11/2004
1	Brain Diseases (Brain Disorder) 10/2019
1	Cognitive Dysfunction 04/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2017
1	Psychomotor Disorders 11/2013
1	Cerebellar Diseases (Cerebellar Syndrome) 09/2013
1	Hallucinations (Hallucination) 08/2013
1	Mental Disorders (Mental Disorder) 08/2010
1	Panic Disorder (Panic Attack) 08/2010
1	Social Phobia 08/2010
1	Stress Urinary Incontinence 09/2008
1	Urinary Retention 09/2008
1	Mood Disorders (Mood Disorder) 05/2007
1	Edema (Dropsy) 04/2007
1	Pulmonary Embolism 05/2006
1	Rhabdomyolysis 05/2006
1	Paranoid Schizophrenia (Delusional Disorder) 07/2004
1	Alzheimer Disease (Alzheimer's Disease) 09/2002

Drug/Important Bio-Agent (IBA)

28	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2004
11	Olanzapine (Zyprexa)FDA Link 01/2022 - 02/2004
7	Clozapine (Clozaril)FDA LinkGeneric 12/2019 - 01/2004
6	Amisulpride (Solian)IBA 01/2022 - 01/2004
6	Aripiprazole (Abilify)FDA Link 02/2017 - 07/2009
6	Glutamic Acid (Glutamate)FDA Link 11/2016 - 03/2005
5	Pharmaceutical PreparationsIBA 04/2017 - 09/2012
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2016 - 12/2009
3	Biological ProductsIBA 10/2019 - 06/2005
3	agomelatine (S20098)IBA 03/2019 - 12/2016
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2018 - 09/2008
3	Dopamine (Intropin)FDA LinkGeneric 08/2018 - 01/2013
3	Risperidone (Risperdal Consta)FDA LinkGeneric 09/2014 - 07/2004
2	ProlactinIBA 02/2017 - 09/2010
2	Polytetrafluoroethylene (Teflon)FDA Link 01/2017 - 04/2016
2	Antidepressive Agents (Antidepressants)IBA 12/2016 - 05/2007
2	Messenger RNA (mRNA)IBA 11/2016 - 01/2012
2	Amino Acids FDA Link 11/2014 - 06/2013
2	Bupropion (Wellbutrin)FDA LinkGeneric 11/2013 - 09/2010
2	gamma-Aminobutyric Acid (GABA)IBA 06/2013 - 03/2005
2	N-Methylaspartate (NMDA)IBA 09/2011 - 01/2008
2	ziprasidone (Geodon)FDA Link 01/2011 - 09/2010
2	Neurotransmitter Agents (Neurotransmitter)IBA 08/2010 - 03/2005
2	Ethanol (Ethyl Alcohol)IBA 03/2005 - 11/2004
1	N 30IBA 03/2022
1	Nootropic Agents (Nootropics)IBA 08/2018
1	5-HT2C Serotonin ReceptorIBA 12/2016
1	OrnithineIBA 11/2016
1	(beta- mercapto- beta,beta- cyclopentamethylenepropionic acid)- O- methyl- Tyr(2)- Thr(4)- Orn(8)- Tyr(9)- NH2 vasotocin (OVTA)IBA 11/2016
1	Oxytocin (Pitocin)FDA LinkGeneric 11/2016
1	Proteins (Proteins, Gene)FDA Link 11/2016
1	Vasotocin (Argiprestocin)IBA 11/2016
1	Oxytocin Receptors (Oxytocin Receptor)IBA 11/2016
1	Paliperidone Palmitate FDA Link 12/2015
1	Alitretinoin FDA Link 10/2015
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 05/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2015
1	Excitatory Amino Acid AgentsIBA 05/2015
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2014
1	Phosphorylcholine (Phosphocholine)IBA 12/2013
1	Phosphorus (Red Phosphorus)IBA 12/2013
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2013
1	glycerophosphoethanolamineIBA 12/2013
1	phosphorylethanolamine (phosphoethanolamine)IBA 12/2013
1	Excitatory Amino AcidsIBA 09/2013
1	Citalopram FDA LinkGeneric 08/2013
1	Drinking WaterIBA 06/2013
1	Aminobutyrates (Aminobutyric Acid)IBA 06/2013
1	BenzodiazepinesIBA 08/2010
1	Pregabalin (Lyrica)FDA Link 08/2010
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 12/2009
1	Serine (L-Serine)FDA Link 12/2009
1	N-acetylaspartate (N-acetyl aspartate)IBA 11/2009
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 09/2008
1	Serotonin (5 Hydroxytryptamine)IBA 09/2008
1	Mirtazapine (Rexer)FDA LinkGeneric 05/2006
1	Butyric Acid (Butanoic Acid)IBA 03/2005
1	Quetiapine Fumarate (Seroquel)FDA Link 07/2004
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 02/2004
1	Rivastigmine (Exelon)FDA LinkGeneric 09/2002
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2002

Therapy/Procedure

5	Therapeutics 02/2016 - 09/2002
3	Polypharmacy 02/2017 - 03/2010
2	Injections 12/2015 - 09/2014